Trials / Unknown
UnknownNCT04675801
SAfety and EFficacy of Bridging Antithrombotic Therapy During Elective Non-cardiac Surgery
Safety and Efficacy of Bridging Antithrombotic Therapy During Elective Non-cardiac Surgery for Coronary Artery Disease Patients Treated With Oral Antiplatelet Agents
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 950 (estimated)
- Sponsor
- Beijing Anzhen Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Patients with coronary artery disease, especially after PCI, require long-term oral antiplatelet therapy. However, this patient population may inevitably require non-cardiac surgery for a variety of conditions. In order to avoid the occurrence of bleeding events, oral antiplatelet agents are usually discontinued before non-cardiac surgery in patients with coronary artery disease, which may increase the incidence of ischemic events. Therefore, it is important to provide patients with the optimal perioperative antithrombotic treatment to balance the risk of bleeding and ischemia.
Conditions
Timeline
- Start date
- 2021-03-02
- Primary completion
- 2023-04-01
- Completion
- 2023-06-01
- First posted
- 2020-12-19
- Last updated
- 2021-11-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04675801. Inclusion in this directory is not an endorsement.